Exelixis | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 2.85B 80M 2025-05
Agios Pharmaceuticals USD 1.72B 21M 2025-05
Amgen USD 150.93B 16.57B 2025-05
AstraZeneca GBP 166.72B 7.79B 2025-05
Bayer EUR 22.54B 839.67M 2025-05
BioMarin Pharmaceutical USD 11.82B 1.73B 2025-05
Bristol-Myers Squibb USD 101.53B 22.57B 2025-05
Cytokinetics USD 3.88B 907M 2025-05
Eisai JPY 1.05T 156.31B 2025-05
Eli Lilly USD 782B 40.35B 2025-05
Exelixis USD 13.18B 2.84B 2025-05
Genmab DKK 83.77B 4.93B 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
Incyte USD 14.04B 2.32B 2025-05
Ionis Pharmaceuticals USD 4.88B 80M 2025-05
MacroGenics USD 204M 3M 2024-12
Merck USD 208.29B 17.59B 2025-05
Moderna USD 10.66B 302M 2025-05
Neurocrine Biosciences USD 10.91B 2.91B 2025-05
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 135.11B 8.61B 2025-05
Takeda JPY 6.71T 309.21B 2025-05
Ultragenyx Pharmaceutical USD 2.9B 495M 2025-05
Xencor USD 500M 1.11B 2025-05



Exelixis Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.